© 2024 Kansas City Public Radio
NPR in Kansas City
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Up To Date

Your Questions About The Coronavirus Vaccine Answered

By Steve Kraske,
Chris Young, Mackenzie Martin
Published January 4, 2021 at 4:23 PM CST
Ways To Subscribe
Close-up photo of a nurse's gloved hands administering a vaccine shot.
National Cancer Institute
/
Unsplash
A new mutation of the coronavirus in the United Kingdom has people concerned about the efficacy of the coronavirus vaccine, but experts say that variant strains in these situations are normal.

Missouri just topped 400,000 coronavirus cases and a new strain of the coronavirus is being reported in the United Kingdom, but experts remain optimistic about vaccines.

The mutations in the coronavirus were to be expected and, from their perspective, the rollout is on track. The necessary minimum goal they advise is 60% herd immunity.

Tags
Up To Date Talk ShowPodcastvaccinesCoronavirusvirusUMKCKansas City Missouri (KCMO)public health
Stay Connected
Steve Kraske
When I host Up To Date each morning at 9, my aim is to engage the community in conversations about the Kansas City area’s challenges, hopes and opportunities. I try to ask the questions that listeners want answered about the day’s most pressing issues and provide a place for residents to engage directly with newsmakers. Reach me at steve@kcur.org or on Twitter @stevekraske.
See stories by Steve Kraske
Chris Young
Chris Young is an Assistant Producer for KCUR’s Up To Date. Contact him at chrisy@kcur.org.
See stories by Chris Young
Mackenzie Martin
Mackenzie Martin is a senior podcast producer at KCUR Studios and host of the podcast, A People's History of Kansas City. Contact her at mackenzie@kcur.org.
See stories by Mackenzie Martin
Support paywall-free journalism
KCUR prides ourselves on bringing local journalism to the public without a paywall — ever.

Our reporting will always be free for you to read. But it's not free to produce.

As a nonprofit, we rely on your donations to keep operating and trying new things. If you value our work, consider becoming a member.
Donate Now